PLoS ONE · 2013 · 121 citations · 49 references
Life SciencesBiochemistryOncologyCell SignalingGene ExpressionSignal TransductionCancer Cell SignalingCancer TranscriptomicsHormone ReceptorsHormone Signal TransductionSignal Transduction In CancerSteroid Hormone SignalingAndrogen Receptor ExpressionBreast Cancer Molecular SubtypesBreast Cancer ProgressionBreast Cancer Resistance MechanismsEstrogen Receptor ExpressionEstrogen Receptor SignalingEstrogen Receptor StatusHormone Resistance Mechanisms
The purpose of this study was to determine the role of long-chain fatty acyl-CoA synthetase 4 (ACSL4) in breast cancer. Public databases were utilized to analyze the relationship between ACSL4 mRNA expression and the presence of steroid hormone and human epidermal growth factor receptor 2 (HER2) in both breast cancer cell lines and tissue samples. In addition, cell lines were utilized to assess the consequences of either increased or decreased levels of ACSL4 expression. Proliferation, migration, anchorage-independent growth and apoptosis were used as biological end points. Effects on mRNA expression and signal transduction pathways were also monitored. A meta-analysis of public gene expression databases indicated that ACSL4 expression is positively correlated with a unique subtype of triple negative breast cancer (TNBC), characterized by the absence of androgen receptor (AR) and therefore referred to as quadruple negative breast cancer (QNBC). Results of experiments in breast cancer cell lines suggest that simultaneous expression of ACSL4 and a receptor is associated with hormone resistance. Forced expression of ACSL4 in ACSL4-negative, estrogen receptor α (ER)-positive MCF-7 cells resulted in increased growth, invasion and anchorage independent growth, as well as a loss of dependence on estrogen that was accompanied by a reduction in the levels of steroid hormone receptors. Sensitivity to tamoxifen, triacsin C and etoposide was also attenuated. Similarly, when HER2-positive, ACSL4-negative, SKBr3 breast cancer cells were induced to express ACSL4, the proliferation rate increased and the apoptotic effect of lapatinib was reduced. The growth stimulatory effect of ACSL4 expression was also observed in vivo in nude mice when MCF-7 control and ACSL4-expressing cells were utilized to induce tumors. Our data strongly suggest that ACSL4 can serve as both a biomarker for, and mediator of, an aggressive breast cancer phenotype.
49
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Daniel R. Rhodes, Jianjun Yu, K. Shanker et al. · Neoplasia · 2004 · 3.7K citations · Full text
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve, Koei Chin, Jane Fridlyand et al. · Cancer Cell · 2006 · 3.2K citations · Full text
Medicine, Cell Biology, Oncology +14
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Yixin Wang, Jan G.M. Klijn, Yi Zhang et al. · The Lancet · 2005 · 2.7K citations
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat, Joel S. Parker, Olga Karginova et al. · Breast Cancer Research · 2010 · 2.1K citations · Full text